Migraine and patent foramen ovale: connecting flight or one-way ticket?

References

• Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology62, 1439–1440 (2004).
   PubMed Web of Science ®Google Scholar
• Tepper SJ, Sheftell FD, Bigal ME. The patent foramen ovale-migraine question. Neurol. Sci.28(Suppl. 2), S118–S123 (2007).
   Google Scholar
• Schwedt TJ, Dodick DW. Patent foramen ovale and migraine – bringing closure to the subject. Headache46, 663–671 (2006).
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia28, 531–540 (2008).
   PubMed Web of Science ®Google Scholar
• Diener HC, Kurth T, Dodick D. Patent foramen ovale, stroke, and cardiovascular disease in migraine. Curr. Opin. Neurol.20, 310–319 (2007).
   PubMedGoogle Scholar
• Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart90, 1315–1320 (2004).
   PubMed Web of Science ®Google Scholar
• Ferrarini G, Malferrari G, Zucco R, Gaddi O, Norina M, Pini LA. High prevalence of patent foramen ovale in migraine with aura. J. Headache Pain6, 71–76 (2005).
   PubMedGoogle Scholar
• Agostoni E, Fumagalli L, Santoro P, Ferrarese C. Migraine and stroke. Neurol. Sci.25(Suppl. 3), S123–S125 (2004).
   Google Scholar
• Kruit MC, van Buchem MA, Hofman PA et al. Migraine as a risk factor for subclinical brain lesions. JAMA291, 427–434 (2004).
   PubMed Web of Science ®Google Scholar
• Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA296, 283–291 (2006).
   PubMed Web of Science ®Google Scholar
• Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke. Cerebrovasc. Dis.13, 102–106 (2002).
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Nedeltchev K, Lagger F et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology65, 1415–1418 (2005).
   PubMed Web of Science ®Google Scholar
• Del Sette M, Angeli S, Leandri M et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case–control study. Cerebrovasc. Dis.8, 327–330 (1998).
   PubMed Web of Science ®Google Scholar
• Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology52, 1622–1625 (1999).
   PubMed Web of Science ®Google Scholar
• Dalla Volta G, Guindani M, Zavarise P, Griffini S, Pezzini A, Padovani A. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J. Headache Pain6, 328–330 (2005).
   PubMedGoogle Scholar
• Carod-Artal FJ, da Silveira Ribeiro L, Braga H, Kummer W, Mesquita HM, Vargas AP. Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study. Cephalalgia26, 934–939 (2006).
   PubMed Web of Science ®Google Scholar
• Tembl J, Lago A, Sevilla T, Solis P, Vilchez J. Migraine, patent foramen ovale and migraine triggers. J. Headache Pain8, 7–12 (2007).
   PubMedGoogle Scholar
• Domitrz I, Mieszkowski J, Kaminska A. Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine. Headache47, 1311–1318 (2007).
   PubMedGoogle Scholar
• Anzola GP, Meneghetti G, Zanferrari C, Adami A, Dinia L, Del Sette M; SAM Study Group. Is migraine associated with right-to-left shunt a separate disease? Results of the SAM study. Cephalalgia28, 360–366 (2008).
   PubMed Web of Science ®Google Scholar
• Cutrer FM, O’Donnell A, Sanchez del Rio M. Functional neuroimaging: enhanced understanding of migraine pathophysiology. Neurology55, S36–S45 (2000).
   Google Scholar
• Kruit MC, van Buchem MA, Hofman PA et al. Migraine as a risk factor for subclinical brain lesions. JAMA291, 427–434 (2004).
   PubMed Web of Science ®Google Scholar
• Rocca MA, Ceccarelli A, Falini A et al. Diffusion tensor magnetic resonance imaging at 3.0 tesla shows subtle cerebral grey matter abnormalities in patients with migraine. J. Neurol. Neurosurg. Psychiatry77, 686–689 (2006).
   PubMedGoogle Scholar
• Del Sette M, Dinia L, Bonzano L et al. White matter lesions in migraine and right-to-left shunt: a conventional and diffusion MRI study. Cephalalgia28, 376–382 (2008).
   PubMedGoogle Scholar
• Intiso D, Di Rienzo F, Rinaldi G et al. Brain MRI white matter lesions in migraine patients: is there a relationship with antiphospholipid antibodies and coagulation parameters? Eur. J. Neurol.13, 1364–1369 (2006).
   PubMedGoogle Scholar
• Rigatelli G, Hijazi ZM. Intracardiac echocardiography in cardiovascular catheter-based interventions: different devices for different purposes. J. Invasive Cardiol.18, 225–233 (2006).
   PubMedGoogle Scholar
• Jesurum JT, Fuller CJ, Velez CA et al. Migraineurs with patent foramen ovale have larger right-to-left shunt despite similar atrial septal characteristics. J. Headache Pain8, 209–216 (2007).
   PubMedGoogle Scholar
• Rigatelli G, Dell’Avvocata F, Cardaioli P et al. The association of different right atrium anatomical-functional characteristics correlates with the risk of paradoxical stroke: an intracardiac echocardiographic study. J. Intervent. Cardiol. (In Press).
   Google Scholar
• Rigatelli G, Dell’Avvocata F, Cardaioli P et al. Migraine-patent foramen ovale connection: role of prominent Eustachian valve and large Chiari’s network in migrainous patients. Am. J. Med. Sci. (In Press).
   Google Scholar
• Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul. Fibrinolysis14, 261–268 (2003).
   PubMed Web of Science ®Google Scholar
• Giardini A, Donti A, Formigari R et al. Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale. Int. J. Cardiol.120, 357–362 (2007).
   PubMed Web of Science ®Google Scholar
• Rigatelli G, Braggion G, Aggio S, Chinaglia M, Cardaioli P. Primary patent foramen ovale closure to relieve severe migraine. Ann. Intern. Med.144, 458–459 (2006).
   PubMedGoogle Scholar
• Rigatelli G, Cardaioli P, Dell’Avvocata F et al. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices type. Cardiovasc. Revasc. Med. (In Press).
   Google Scholar
• Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet356, 1648–1651 (2000).
   PubMed Web of Science ®Google Scholar
• Schwerzmann M, Wiher S, Nedeltchev K et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology62, 1399–1401 (2004).
   PubMed Web of Science ®Google Scholar
• Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J. Am. Coll. Cardiol.45, 489–492 (2005).
   PubMed Web of Science ®Google Scholar
• Reisman M, Christofferson RD, Jesurum J et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J. Am. Coll. Cardiol.45, 493–495 (2005).
   PubMed Web of Science ®Google Scholar
• Mortelmans K, Post M, Thijs V, Herroelen L, Budts W. The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur. Heart J.26, 1533–1537 (2005).
   PubMed Web of Science ®Google Scholar
• Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: a case–control study. Stroke37, 430–434 (2006).
   PubMed Web of Science ®Google Scholar
• Giardini A, Donti A, Formigari R et al. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke. Catheter Cardiovasc. Interv.67, 625–629 (2006).
   PubMed Web of Science ®Google Scholar
• Kimmelstiel C, Gange C, Thaler D. Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study. Catheter Cardiovasc. Interv.69, 740–746 (2007).
   PubMedGoogle Scholar
• Rigatelli G, Cardaioli P, Braggion G et al. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia Catheter Cardiovasc. Interv.70, 429–433 (2007).
   PubMedGoogle Scholar
• Dowson A, Mullen MJ, Peatfield R et al. Migraine Intervention With STARFlex Technology (MIST) Trial. A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation117, 1397–1404 (2008).
   PubMed Web of Science ®Google Scholar
• Rigatelli G, Cardaioli P, Dell’Avvocata F, Giordan M, Braggion G, Chinaglia M. Transcatheter interatrial shunt closure as a cure for migraine: can it be justified by paradoxical embolism – risk driven criteria? Am. J. Med. Sci. (In Press).
   Google Scholar
• Krumsdorf U, Ostermayer S, Billinger K et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J. Am. Coll. Cardiol.43, 302–309 (2004).
   PubMed Web of Science ®Google Scholar
• Taaffe M, Fischer E, Baranowski A et al. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am. J. Cardiol.101, 1353–1358 (2008).
   PubMedGoogle Scholar